$1.35M awarded for needle-free Zika virus vaccine
Dr Branka Grubor-Bauk and her Viral Immunology Group at the Basil Hetzel Institute, TQEH, have been awarded funding from the highly competitive Biomedical Translation Bridge (BTB) program (part of the Medical Research Future Fund) to develop a novel needle-free vaccine to prevent infection of pregnant women with Zika virus. The technology, developed in collaboration with industry partner Enesi Pharma, Oxford, UK, combines protective Zika virus DNA vaccine with Enesi Pharma’s ImplaVax® Technology. If you are curious about how needle-free vaccination works watch this video!
More detail: The University of Adelaide, The Hospital Research Foundation
